Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
Settings
TROV TrovaGene, Inc. daily Stock Chart
TROV [NASD]
TrovaGene, Inc.
Index- P/E- EPS (ttm)-1.09 Insider Own0.80% Shs Outstand29.73M Perf Week5.77%
Market Cap114.46M Forward P/E- EPS next Y-1.17 Insider Trans14.43% Shs Float26.91M Perf Month-23.91%
Income-24.80M PEG- EPS next Q-0.25 Inst Own35.50% Short Float13.09% Perf Quarter-22.54%
Sales0.30M P/S381.53 EPS this Y-8.60% Inst Trans0.33% Short Ratio5.27 Perf Half Y-41.67%
Book/sh1.92 P/B2.01 EPS next Y-11.40% ROA-50.80% Target Price10.17 Perf Year-34.19%
Cash/sh2.49 P/C1.54 EPS next 5Y- ROE-94.60% 52W Range2.85 - 13.58 Perf YTD-28.70%
Dividend- P/FCF- EPS past 5Y-9.20% ROI-63.90% 52W High-71.65% Beta-0.64
Dividend %- Quick Ratio10.70 Sales past 5Y-15.60% Gross Margin-33.30% 52W Low35.09% ATR0.52
Employees31 Current Ratio10.70 Sales Q/Q0.20% Oper. Margin- RSI (14)44.37 Volatility9.18% 15.46%
OptionableYes Debt/Eq0.28 EPS Q/Q67.90% Profit Margin- Rel Volume0.50 Prev Close3.98
ShortableYes LT Debt/Eq0.21 EarningsMar 10 AMC Payout- Avg Volume668.51K Price3.85
Recom1.80 SMA20-3.53% SMA50-23.31% SMA200-45.98% Volume336,136 Change-3.27%
Feb-03-16Reiterated Maxim Group Buy $13 → $12
Sep-16-15Initiated Cantor Fitzgerald Buy
Aug-14-15Initiated Leerink Partners Outperform
Apr-20-15Reiterated Maxim Group Buy $10 → $13
Jul-10-14Initiated Maxim Group Buy $10
Nov-13-13Reiterated Aegis Capital Buy $14 → $10
Oct-01-13Reiterated Aegis Capital Buy $14
Jul-16-13Initiated Cantor Fitzgerald Buy $10
Apr-01-13Reiterated Aegis Capital Buy $12 → $14
Dec-12-12Initiated Aegis Capital Buy $12
Feb-01-16 01:14PM  Heres Why TrovaGene (TROV) Stock is Soaring Today at TheStreet +15.11%
12:58PM  Why TrovaGene (TROV) Stock is Surging Today
11:15AM  Could This Be the Turning Point for TrovaGene? at 24/7 Wall St.
10:31AM  Here's Why Shares Of TrovaGene Are Surging
06:29AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
03:29AM  Trovagene Enters into Agreement with FedMed, Inc. and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform at noodls
03:00AM  Trovagene Enters into Agreement with FedMed, Inc. and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform PR Newswire
Jan-21-16 04:27PM  Why Is Trovagene Inc. (TROV) Stock Soaring Today? +69.85%
02:28PM  Trovagene (TROV) Stock Soars on America's Choice Provider Network Partnership at TheStreet
01:01PM  Heres Whats Pushing These 5 Stocks Higher Today at Insider Monkey
11:34AM  4 Nasdaq Stocks That Are Trading Higher Today Accesswire
10:38AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:15AM  Trovagene Announces Agreement with America's Choice Provider Network to Offer Patients Access to its ctDNA Precision Cancer Monitoring Platform PR Newswire
Jan-13-16 04:21PM  TROVAGENE, INC. Files SEC form 8-K/A, Other Events
Jan-11-16 08:43AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -14.89%
Jan-07-16 04:17PM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers -7.71%
Dec-24-15 10:28AM  TrovaGene, Inc. Earnings Analysis: Q3, 2015 By the Numbers
07:50AM  How it All Plays Out - Analyst Notes on Bazaarvoice, Straight Path Communications, Trovagene and Eldorado Resorts Accesswire
Dec-23-15 04:24PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
Dec-17-15 02:45PM  TrovaGene (TROV) Receives New Patent for PCM Technology -5.17%
Dec-16-15 04:06PM  TROVAGENE, INC. Files SEC form 8-K, Other Events +5.84%
08:15AM  Trovagene Announces Patent Issuance, Broadening its Precision Cancer Monitoring IP Portfolio PR Newswire
Dec-15-15 04:17PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendment or Waiver to Code of Ethics +8.73%
Dec-11-15 11:51AM  Funds Hold These 4 Favorably-Ranked Stocks: Do You?
08:32AM  How TrovaGene (TROV) Stock Stands Out in a Strong Industry
Dec-09-15 04:05PM  Trovagene Adjourns Special Meeting of Stockholders to December 23, 2015 PR Newswire -5.39%
Dec-08-15 01:17PM  TROVAGENE, INC. Financials
Nov-30-15 09:39AM  What Hedge Funds Think About TriplePoint Venture Growth BDC Corp (TPVG) at Insider Monkey -6.92%
Nov-27-15 08:05AM  Can The Uptrend Continue for TrovaGene (TROV)?
Nov-25-15 09:16AM  TROVAGENE, INC. Files SEC form 8-K, Other Events +6.73%
08:15AM  Trovagene to Present at 27th Annual Piper Jaffray Healthcare Conference and Attend Evercore ISI Investor Conference PR Newswire
Nov-20-15 08:30AM  A Look Inside the Chart, Technical Insights - Research on Tilly's, Geospace Technologies, Synthetic Biologics and TrovaGene Accesswire
Nov-19-15 04:17PM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Nov-16-15 08:05AM  Trovagene to Present at Upcoming Healthcare Conferences PR Newswire
07:58AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Nov-10-15 09:50AM  TrovaGene Rallies despite Wider-than-Expected Q3 Loss +16.30%
12:22AM  Edited Transcript of TROV earnings conference call or presentation 9-Nov-15 10:00pm GMT
Nov-09-15 06:35PM  Trovagene reports 3Q loss
04:22PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:05PM  Trovagene, Inc. Announces Third Quarter 2015 Financial Results PR Newswire
07:07AM  Q3 2015 Trovagene Inc Earnings Release - 4:00 pm ET
Nov-06-15 06:30PM  What's in Store for TrovaGene (TROV) Ahead of Q3 Earnings?
11:06AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:15AM  Clinical Data Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics PR Newswire
Oct-27-15 01:26PM  TrovaGene, Inc. Value Analysis (NASDAQ:TROV) : October 27, 2015
09:45AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:15AM  Trovagene's Urine-Based Liquid Biopsy Platform Shows Clinical Sensitivity of 93 Percent in Lung Cancer Study PR Newswire
Oct-15-15 08:05AM  Trovagene Schedules Release of Third Quarter 2015 Financial Results and Investor Conference Call PR Newswire +11.07%
Oct-08-15 04:05PM  Practical Clinical Benefits of Trovagene's Urine-Based Liquid Biopsy Platform Demonstrated in Field Experience Analysis PR Newswire
Oct-07-15 08:14AM  Pharmaceutical Sector Due Diligence Report - Searching for Opportunities Among the Bruised Small Cap Market Accesswire +6.37%
Oct-01-15 10:29AM  TrovaGene, Inc. Earnings Q2, 2015 -8.08%
Sep-28-15 11:31AM  Three Stocks Fall on Monday but Hedge Fund Data Suggests You Might Want to Buy Some of Them on the Drop at Insider Monkey -11.11%
Sep-24-15 08:26AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Clinical Data for Trovagene's Precision Cancer Monitoring Platform Presented at the European Cancer Congress PR Newswire
Sep-22-15 12:20PM  TrovaGene Unveils Positive HPV HR Test Data at Lisbon Meet
Sep-21-15 02:27PM  ETFs with exposure to TrovaGene, Inc. : September 21, 2015
10:38AM  TrovaGene, Inc. breached its 50 day moving average in a Bullish Manner : September 21, 2015
09:41AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Results from Second Large-Scale Clinical Trial for Trovagene's Urine-based HPV Test Released PR Newswire
Sep-16-15 02:22PM  Cantor Says Trovagene's Liquid Biopsies Have '10x The Kick,' Is Buying In
Sep-11-15 12:50PM  TrovaGene Fortifies European Hold with New Institute, Tie-Up
Sep-10-15 01:00PM  Trovagene Presents Positive PCM Data at Denver Conference
12:34PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
03:00AM  Trovagene Forms European Institute with Alberto Bardelli, Ph.D.; Core Technologies Transferred from University of Torino PR Newswire
Sep-09-15 09:22AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Trovagene's Urine-Based Liquid Biopsy Platform Shown to Detect Impact of Cancer Therapy within 24 Hours PR Newswire
Aug-18-15 11:29AM  TROVAGENE, INC. Files SEC form 8-K, Other Events -6.47%
08:05AM  Trovagene to Present Clinical Data and Capabilities of Its Urine-Based Liquid Biopsy Platform at the 7th Annual Next Generation Dx Summit PR Newswire
Aug-14-15 09:18AM  Leerink: Trovagene Is A Pure Play That Should Outperform
07:08AM  Coverage initiated on TrovaGene by Leerink Partners
Aug-13-15 09:40AM  Insiders Are Buying Up Shares Of Sothebys (BID), Summit Hotel Properties Inc (INN), and TrovaGene Inc (TROV) at Insider Monkey
Aug-12-15 12:50PM  Psychemedics Corp. Earnings Q2*, 2015 +10.52%
Aug-11-15 09:00AM  TrovaGene Q2 Loss Widens on Higher Expenses, Shares Fall - Analyst Blog -13.69%
Aug-10-15 10:06PM  Edited Transcript of TROV earnings conference call or presentation 10-Aug-15 9:00pm GMT
06:13PM  Trovagene reports 2Q loss
04:14PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:09PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  Trovagene, Inc. Announces Second Quarter 2015 Financial Results PR Newswire
07:07AM  Q2 2015 Trovagene Inc Earnings Release - 4:00 pm ET
Aug-07-15 03:40PM  TrovaGene (TROV): What???s in Store this Earnings Season? - Analyst Blog
Jul-23-15 11:49AM  5 Health Care Stocks Under $10 Set to Soar at TheStreet -5.82%
10:30AM  Bridger Management Inceases Its Stake In TrovaGene Inc. (TROV) Via Its SPO at Insider Monkey
08:15AM  Trovagene Schedules Release of Second Quarter 2015 Financial Results and Investor Conference Call PR Newswire
Jul-22-15 04:16PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +6.87%
10:12AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock PR Newswire
Jul-17-15 03:22PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -9.28%
03:16PM  TrovaGene (TROV) Stock Tanks After Pricing Secondary Offering at TheStreet
09:00AM  Trovagene, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire
Jul-16-15 04:48PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:29PM  Trovagene, Inc. Announces Public Offering of Common Stock PR Newswire
Jul-09-15 01:40PM  Trovagene's PCM to Monitor Melanoma Patients in New Study - Analyst Blog
Jul-08-15 09:49AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:10AM  Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform PR Newswire
Jul-07-15 12:02PM  TROVAGENE, INC. Files SEC form 8-K, Other Events -5.25%
08:05AM  Trovagene Inc. to Present at Cantor Fitzgerald's Inaugural Healthcare Conference PR Newswire
Jul-06-15 11:10AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.98%
Jun-29-15 10:08AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes PR Newswire
Jun-26-15 09:45AM  Four Small Cap Stocks Overlooked by Wall Street Accesswire
Jun-25-15 06:40PM  WRLD, TROV, MEI: Biggest Losers Of The Day And What Hedge Funds Think About Them at Insider Monkey -12.49%
Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It is developing PCM BRAF and KRAS mutation detection tests for detecting mutations in metastatic cancer patients; and HPV HR detection test to detect the presence of various HPV genotypes using a urine sample. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tennant StanleyDirectorAug 12Buy6.0610,00060,600192,762Aug 12 04:50 PM
SCHUH ANTONIUSCEOAug 12Buy5.4520,000109,00020,000Aug 12 04:35 PM
BRIDGER MANAGEMENT, LLC10% OwnerJul 17Buy8.75140,0001,225,0003,290,587Jul 21 05:27 PM
BRIDGER MANAGEMENT, LLC10% OwnerApr 02Buy6.90300,0002,070,0003,150,587Apr 06 05:00 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 27Buy5.6279,343445,9082,850,587Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 26Buy5.4278,801427,1012,771,244Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 25Buy5.12105,142538,3272,692,443Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 06Buy4.50444,4441,999,9982,587,301Feb 10 04:25 PM